Fortis Healthcare Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter
- September 15, 2026
- Posted by: Harsh Piplani
- Category: Results
Fortis Healthcare share price Rs 885.40 on 15 September 2026, down 0.27%. Q2 FY27 results date not confirmed. Q1 FY27 net profit Rs 273.00 crore. Q2 FY26 base a profit of Rs 329.00 crore.
Quick Answer
The Fortis Healthcare Q2 results date for FY27 is not confirmed, and Fortis Healthcare Ltd. had not filed a board meeting intimation with the NSE or BSE as of 15 September 2026. Indian listing rules require the September 2026 quarter results to be published within 45 days of the quarter end, an outer deadline of 14 November 2026. The quarter will be measured against a September 2025 base of Rs 2,331.00 crore in revenue and a profit of Rs 329.00 crore. This preview uses reported actuals only and carries no estimated revenue or profit figure for the coming quarter.
The Fortis Healthcare Q2 results FY27 announcement is the next scheduled earnings event for Fortis Healthcare Ltd., runs a chain of hospitals and diagnostic and other healthcare services across India. The stock traded at Rs 885.40 on the NSE on 15 September 2026, down 0.27% from the previous close of Rs 887.80, about 19.8% below its 52-week high of Rs 1,104.30 and 15.5% above its 52-week low of Rs 766.80.
What makes the Fortis Healthcare Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 2,331.00 crore of revenue and a profit of Rs 329.00 crore, while the most recent quarter on record, Q1 FY27, produced Rs 2,545.00 crore and a profit of Rs 273.00 crore. Everything below is built from those reported figures rather than from any forecast.
Click Here – Get Free Investment Predictions
When Is the Fortis Healthcare Q2 Results FY27 Date?
The Fortis Healthcare Q2 results date for FY27 is not confirmed. As of 15 September 2026, Fortis Healthcare Ltd. had not filed a board meeting intimation with the NSE or BSE for the September 2026 quarter, so any date circulating before that filing appears should be treated as unverified.
What can be stated is the regulatory boundary. Listed companies in India must publish quarterly results within 45 days of the end of the quarter, which places the outer deadline for the September 2026 quarter at 14 November 2026. Companies also have to give the exchanges prior intimation of the board meeting that approves the results, so the Fortis Healthcare Q2 results date becomes public through that filing rather than through any advance announcement.
The Fortis Healthcare Q2 results FY27 print covers 1 July 2026 to 30 September 2026. Small and mid-cap companies more often report in the second half of that window than in the first, so late October or early November is the range to watch for Fortis Healthcare.
Fortis Healthcare Q2 Results Expectations: What the Market Is Actually Tracking
No verified analyst estimate for the Fortis Healthcare Q2 results FY27 quarter is in the public domain, so no revenue or profit figure should be assumed for Fortis Healthcare. The Fortis Healthcare Q2 results watchlist below is built from what the company has actually reported and disclosed.
Investors tracking Fortis Healthcare Q2 results will be watching whether the hospital operator can hold operating margins near the 21-24% band seen over the last five quarters, after revenue rose from Rs 2,167 crore in the June 2025 quarter to Rs 2,545 crore in June 2026. Operating profit moved in a relatively narrow range between Rs 491 crore and Rs 556 crore across the same period, while operating margin eased slightly to 21% in June 2026 from a high of 24% in September 2025. Net profit, however, has been less consistent, falling to Rs 197 crore in December 2025 from Rs 267 crore and Rs 329 crore in the two preceding quarters. Whether the September 2026 quarter profit trend looks more like the December 2025 dip or the stronger readings around it will be a key watch point.
The December 2025 net profit dip is flagged in the underlying data as not fully explained by available disclosures, and could reflect a below-the-line item such as an impairment, tax adjustment or minority interest swing rather than a core operating issue, since operating profit for that quarter (Rs 506 crore) was broadly in line with adjacent quarters. This makes December 2025 a less reliable base for a clean quarter-on-quarter comparison heading into the September 2026 quarter. Revenue growth across the five quarters has been steady rather than volatile, moving from Rs 2,167 crore to Rs 2,545 crore, suggesting the underlying hospital and diagnostics business has continued to expand even as net profit bounced around.
Investors will also be watching whether Fortis can sustain the operating margin seen in June 2026 (21%) versus the softer patch, and whether net profit for the September 2026 quarter tracks closer to the Rs 267-329 crore range seen in the first two quarters of this data set rather than the December 2025 low. The stock’s market capitalization is down roughly 8.5% year-on-year despite broadly steady operating performance, according to the underlying notes, which is worth keeping in mind when assessing how the market has priced recent results. Promoter holding of 31.2% provides some context on ownership structure heading into the results season.
Check Fortis Healthcare Ltd. Live Fundamentals on the Univest Screener
Fortis Healthcare Q2 Results Preview: The Q1 FY27 Actuals It Builds On
Fortis Healthcare Ltd. reported revenue of Rs 2,545.00 crore in Q1 FY27, up 17.44% from Rs 2,167.00 crore in Q1 FY26, and a profit of Rs 273.00 crore at the net level, up 2.25% from Rs 267.00 crore in Q1 FY26. These are reported actuals, not estimates.
Sequentially, revenue was up 7.61% over the March 2026 quarter figure of Rs 2,365.00 crore, and net profit was up 0.74% from Rs 271.00 crore in Q4 FY26. Operating margin stood at 23.0% in Q1 FY27 against 24.0% in the September 2025 quarter, which is the comparison the Fortis Healthcare Q2 results print will be read against.
Q2 FY26 Base: The Comparison Fortis Healthcare Q2 Results FY27 Must Beat
Fortis Healthcare Ltd. reported revenue of Rs 2,331.00 crore and a profit of Rs 329.00 crore in Q2 FY26, the September 2025 quarter. That is the year-ago base against which the September 2026 numbers will be judged, and it is the single most useful figure in this Fortis Healthcare Q2 results preview.
Net profit in that base quarter was above the Rs 273.00 crore just reported for Q1 FY27, so the year-on-year comparison starts from a demanding level. Revenue of Rs 2,331.00 crore sits below the Rs 2,545.00 crore of the June 2026 quarter, which frames how much sequential movement the Fortis Healthcare Q2 results print needs to show growth.
Fortis Healthcare Quarterly Results Trend Over the Last Four Quarters
| Quarter | Revenue (Rs Cr) | Net Profit (Rs Cr) |
|---|---|---|
| Q2 FY26 (Sep 2025) | 2,331.00 | 329.00 |
| Q3 FY26 (Dec 2025) | 2,265.00 | 197.00 |
| Q4 FY26 (Mar 2026) | 2,365.00 | 271.00 |
| Q1 FY27 (Jun 2026) | 2,545.00 | 273.00 |
Figures in brackets denote negative numbers. All four quarters above are reported actuals taken from the company’s exchange filings, and they are the only basis this Fortis Healthcare Q2 results preview uses.
Revenue across those four quarters ranged from Rs 2,265.00 crore to Rs 2,545.00 crore, and net profit from Rs 197.00 crore to Rs 329.00 crore. That spread is the honest context for the Fortis Healthcare Q2 results FY27 print, and it is why a single quarter should not be read as a trend on its own.
Key Factors That Could Shape Fortis Healthcare Q2 Results FY27
The Fortis Healthcare Q2 results outcome will turn on a small number of company-specific variables rather than on broad market conditions. The three below are the ones visible in what Fortis Healthcare has already reported.
Valuation snapshot
Fortis Healthcare trades at a trailing P/E of 62.8 and a price-to-book multiple of 6.76 against a book value of Rs 131 per share, with the stock at around Rs 885. Return on equity of 11.2% and return on capital employed of 13.4% are moderate for a hospital operator, and sit alongside a valuation multiple that prices in continued growth. These figures give investors a reference point for judging whether the September 2026 quarter results support the current valuation.
Price and technical setup
Fortis shares, at around Rs 885, are trading below the 50-day moving average of Rs 931.43 and close to the 200-day moving average of Rs 912.21, and sit well off the 52-week high of Rs 1,104.3 while still above the 52-week low of Rs 766.8. The relative strength index of 32.41 is on the lower end of the neutral range, closer to oversold territory, heading into the results announcement.
Balance sheet and dividend
The company carries a debt-to-equity ratio of 0.35, a moderate level of borrowing for a capital-intensive hospital business. Dividend yield is low at 0.11%, in line with a company still expanding its bed capacity and hospital network. These balance sheet metrics provide context for how much financial flexibility Fortis has heading into the September 2026 quarter.
Fortis Healthcare Q2 Results FY27: Share Price and Valuation Going Into the Print
Fortis Healthcare share price today is Rs 885.40 on the NSE, down Rs 2.40 or 0.27% from the previous close of Rs 887.80 on 15 September 2026, ahead of the Fortis Healthcare Q2 results announcement.
| Metric | Value (15 September 2026) |
|---|---|
| NSE Symbol | FORTIS |
| Current Market Price | Rs 885.40 |
| 52-Week High | Rs 1,104.30 |
| 52-Week Low | Rs 766.80 |
| Market Capitalisation | Rs 67,025 crore |
| PE Ratio | 62.80 |
| PB Ratio | 6.76 |
| EPS (TTM) | Rs 14.10 |
| Book Value per Share | Rs 131.00 |
| Debt to Equity | 0.35 |
| Return on Equity | 11.2% |
| 50-Day Moving Average | Rs 931.43 |
| 200-Day Moving Average | Rs 912.21 |
| RSI (14) | 32.41 |
The stock trades below both its 50-day average of Rs 931.43 and its 200-day average of Rs 912.21, with a 14-day RSI of 32.41. None of this is a view on where the shares go once the Fortis Healthcare Q2 results are announced, and no price target is offered here.
Download the Univest iOS App or Univest Android App to track Fortis Healthcare Ltd. live price and quarterly earnings updates.
What Investors Should Watch When Fortis Healthcare Q2 Results Are Announced
Four lines carry most of the information in a company of this size, and reading them in order keeps the Fortis Healthcare Q2 results print in proportion.
- Revenue against the Rs 2,331.00 crore reported in the September 2025 base quarter
- Net profit against a profit of Rs 329.00 crore in that same quarter
- Operating margin against 23.0% in Q1 FY27
- Any exceptional item, provision or one-off gain disclosed alongside the numbers
A one-off gain or provision can move the reported profit far more than operations do in a company this size, which is why the Fortis Healthcare Q2 results announcement should be read together with the notes to the results rather than the headline alone.
Conclusion on Fortis Healthcare Q2 Results FY27
The Fortis Healthcare Q2 results date is not confirmed, and 14 November 2026 is the statutory outer limit rather than an expected date. Fortis Healthcare Ltd. will make the schedule public through a board meeting intimation to the exchanges, and until then the September 2026 quarter can only be framed by what has already been reported.
On that basis the Fortis Healthcare Q2 results FY27 print faces a base of Rs 2,331.00 crore in revenue and a profit of Rs 329.00 crore, with the most recent quarter having delivered Rs 2,545.00 crore and a profit of Rs 273.00 crore. No numerical estimate appears in this preview because no verified consensus figure exists for Fortis Healthcare, and readers should treat any preview that supplies one with caution. Verify every figure against the company filing on release and consult a SEBI-registered advisor before acting on quarterly earnings.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Fortis Healthcare Q2 Results FY27
What is the Fortis Healthcare Q2 results date for FY27?
Ans. The Fortis Healthcare Q2 results date for FY27 is not confirmed. Fortis Healthcare Ltd. had not filed a board meeting intimation with the NSE or BSE as of 15 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.
What quarter do the Fortis Healthcare Q2 results 2026 cover?
Ans. The Fortis Healthcare Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Fortis Healthcare Ltd. reports revenue, operating profit and net profit for that period, and the Fortis Healthcare Q2 results filing also carries the notes to the accounts.
What were the Fortis Healthcare Q1 FY27 results?
Ans. Fortis Healthcare Ltd. reported revenue of Rs 2,545.00 crore in Q1 FY27 and a profit of Rs 273.00 crore at the net level. Revenue was up 17.44% versus Q1 FY26 and net profit was up 2.25% from Rs 267.00 crore in Q1 FY26.
What were Fortis Healthcare Q2 FY26 results in the September 2025 quarter?
Ans. Fortis Healthcare Ltd. reported revenue of Rs 2,331.00 crore and a profit of Rs 329.00 crore in Q2 FY26. Operating margin was 24.0%. Those figures form the base for the Fortis Healthcare Q2 results FY27 comparison.
What are the main Fortis Healthcare Q2 results expectations this quarter?
Ans. No verified analyst estimate is publicly available. The Fortis Healthcare Q2 results expectations centre on revenue against the Rs 2,331.00 crore base, net profit against a profit of Rs 329.00 crore, operating margin against 23.0% in Q1 FY27, and any exceptional item disclosed with the numbers.
What is Fortis Healthcare share price today ahead of the Q2 earnings?
Ans. Fortis Healthcare share price is Rs 885.40 on the NSE as of 15 September 2026, down 0.27% from Rs 887.80. The stock is about 19.8% below its 52-week high of Rs 1,104.30 and 15.5% above its 52-week low of Rs 766.80, at a market capitalisation of Rs 67,025 crore.
Is Fortis Healthcare a good stock to buy before the Q2 results?
Ans. This article does not offer a buy, sell or hold recommendation on Fortis Healthcare Ltd. The stock trades at a price-to-book ratio of 6.76 with a return on equity of 11.2%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.
